Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Summaries of opinion Remove Summaries of opinion filter Withdrawn applications Remove Withdrawn applications filter Paediatric investigation plans Remove Paediatric investigation plans filter Referrals Remove Referrals filter European public assessment reports (EPAR) (669) Apply European public assessment reports (EPAR) filter Orphan designations (213) Apply Orphan designations filter Direct healthcare professional communication (11) Apply Direct healthcare professional communication filter

Product number

Opinion status

Positive (16) Apply Positive filter

Application type

Initial authorisation (7) Apply Initial authorisation filter Post-authorisation (9) Apply Post-authorisation filter

Date of opinion

From:

To:

Withdrawal type

Initial authorisation (62) Apply Initial authorisation filter Post-authorisation (13) Apply Post-authorisation filter

Withdrawal date

From:

To:

PIP decision type

P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) (17) Apply P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) filter PM: decision on the application for modification of an agreed PIP (138) Apply PM: decision on the application for modification of an agreed PIP filter RPM: decision refers to a refusal on the application for modification of an agreed PIP (1) Apply RPM: decision refers to a refusal on the application for modification of an agreed PIP filter RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) (1) Apply RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) filter W: decision granting a waiver in all age groups for all conditions or indications (30) Apply W: decision granting a waiver in all age groups for all conditions or indications filter

PIP condition / indication

Pharmaceutical form(s)

Route(s) of administration

Decision date

From:

To:

PIP compliance check

Yes (18) Apply Yes filter

Compliance procedure number

Referral name

Referral status

European Commission final decision (17) Apply European Commission final decision filter Opinion provided by Committee for Medicinal Products for Human Use (1) Apply Opinion provided by Committee for Medicinal Products for Human Use filter

Referral safety status

Yes (7) Apply Yes filter

Referral type

Article 20 procedures (12) Apply Article 20 procedures filter Article 31 referrals (6) Apply Article 31 referrals filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC (16) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally and nationally authorised products (mixed) (5) Apply Centrally and nationally authorised products (mixed) filter Centrally authorised product(s) (12) Apply Centrally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures (12) Apply Risk minimisation measures filter Suspension (2) Apply Suspension filter Variation (1) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Medicine type

Additional monitoring Remove Additional monitoring filter Exceptional circumstances Remove Exceptional circumstances filter Generic Remove Generic filter Orphan medicine Remove Orphan medicine filter Accelerated assessment (39) Apply Accelerated assessment filter Biosimilar (4) Apply Biosimilar filter Conditional approval (28) Apply Conditional approval filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

296 results

Remove all filtersRemove all filters

Medicine type Generic Remove Generic filter Orphan medicine Remove Orphan medicine filter Exceptional circumstances Remove Exceptional circumstances filter Additional monitoring Remove Additional monitoring filter

Medicine Paediatric investigation plans Remove Paediatric investigation plans filter Referrals Remove Referrals filter Withdrawn applications Remove Withdrawn applications filter Summaries of opinion Remove Summaries of opinion filter

Categories Human Remove Human filter

Sort by

List item

Summary of opinion: Elzonris

tagraxofusp, opinion date: 23/07/2020, Positive, Last updated: 13/11/2020
List item

Summary of opinion: Xarelto

rivaroxaban, opinion date: 12/11/2020, Positive, Last updated: 13/11/2020
List item

Summary of opinion: Kyprolis

carfilzomib, opinion date: 12/11/2020, Positive, Last updated: 13/11/2020
List item

Summary of opinion: Bavencio

avelumab, opinion date: 10/12/2020, Positive, Last updated: 11/12/2020
List item

Summary of opinion: Lenalidomide Krka d.d. Novo mesto

lenalidomide, opinion date: 10/12/2020, Positive, Last updated: 11/12/2020
List item

Summary of opinion: Lenalidomide KrKa

lenalidomide, opinion date: 10/12/2020, Positive, Last updated: 11/12/2020
List item

Summary of opinion: Doptelet

avatrombopag, opinion date: 10/12/2020, Positive, Last updated: 11/12/2020
List item

Summary of opinion: Spravato

esketamine, opinion date: 10/12/2020, Positive, Last updated: 11/12/2020
List item

Summary of opinion: Sunitinib Accord

sunitinib, opinion date: 10/12/2020, Positive, Last updated: 11/12/2020
List item

Summary of opinion: Lumoxiti

moxetumomab pasudotox, opinion date: 10/12/2020, Positive, Last updated: 11/12/2020
List item

Summary of opinion: Inrebic

fedratinib, opinion date: 10/12/2020, Positive, Last updated: 11/12/2020
List item

Summary of opinion: Lenalidomide Krka d.d.

lenalidomide, opinion date: 10/12/2020, Positive, Last updated: 11/12/2020
List item

Summary of opinion: Tecentriq

atezolizumab, opinion date: 17/09/2020, Positive, Last updated: 18/09/2020
List item

Summary of opinion: Keytruda

pembrolizumab, opinion date: 10/12/2020, Positive, Last updated: 11/12/2020
List item

Summary of opinion: Rinvoq

upadacitinib, opinion date: 10/12/2020, Positive, Last updated: 11/12/2020
List item

Summary of opinion: Dupixent

dupilumab, opinion date: 15/10/2020, Positive, Last updated: 16/10/2020
List item

Withdrawn application: Puldysa (updated)

idebenone, date of withdrawal: 28/10/2020, Initial authorisation, Last updated: 18/01/2021
List item

Withdrawn application: Upkanz

deferiprone, date of withdrawal: 10/08/2020, Initial authorisation, Last updated: 28/10/2020
List item

Withdrawn application: Doxorubicin Hydrochloride Tillomed

doxorubicin, date of withdrawal: 02/03/2020, Initial authorisation, Last updated: 27/07/2020
List item

Withdrawn application: Fingolimod Mylan

fingolimod, date of withdrawal: 08/05/2020, Initial authorisation, Last updated: 17/06/2020
List item

Withdrawn application: Vynpenta (previously AvacopanChemoCentryx)

date of withdrawal: 23/01/2019, Initial authorisation, Last updated: 15/05/2020
List item

Withdrawn application: Keytruda

pembrolizumab, date of withdrawal: 10/12/2019, Post-authorisation, Last updated: 19/03/2020
List item

Withdrawn application: Opsumit

macitentan, date of withdrawal: 08/11/2019, Post-authorisation, Last updated: 17/02/2020
List item

Withdrawn application: Xyndari

date of withdrawal: 18/09/2019, Initial authorisation, Last updated: 11/02/2020
List item

Withdrawn application: Radicava

date of withdrawal: 24/05/2019, Initial authorisation, Last updated: 14/08/2019

Load more

296 results

Summary of opinion: Elzonris

Summary of opinion: Xarelto

Summary of opinion: Kyprolis

Summary of opinion: Bavencio

Summary of opinion: Lenalidomide Krka d.d. Novo mesto

Summary of opinion: Lenalidomide KrKa

Summary of opinion: Doptelet

Summary of opinion: Spravato

Summary of opinion: Sunitinib Accord

Summary of opinion: Lumoxiti

Summary of opinion: Inrebic

Summary of opinion: Lenalidomide Krka d.d.

Summary of opinion: Tecentriq

Summary of opinion: Keytruda

Summary of opinion: Rinvoq

Summary of opinion: Dupixent

Withdrawn application: Puldysa (updated)

Withdrawn application: Upkanz

Withdrawn application: Doxorubicin Hydrochloride Tillomed

Withdrawn application: Fingolimod Mylan

Withdrawn application: Vynpenta (previously AvacopanChemoCentryx)

Withdrawn application: Keytruda

Withdrawn application: Opsumit

Withdrawn application: Xyndari

Withdrawn application: Radicava